• Arcutis: FDA Approves ZORYVE (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older More
• Celularity: Treatment of First Patient in Phase 1/2a Clinical Trial for NK Cell Therapy CYNK-101, in Development for the First-Line Treatment of Advanced HER2 Positive Gastric and Gastroesophageal Junction (G/GEJ) Cancers More
• Centaur Labs: Partners With Mayo Clinic Spin Out Lucem Health to Accelerate Medical AI Development More
• Eliem Therapeutics: Provides ETX-810 Program Update More More*
• Icosavax: Results From IVX-411 Drug Product Investigation and Outlines Additional Corporate Milestones More
• Krystal Biotech: Receives FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial More
• Landos Biopharma: Positive Top-Line Results From NX-13 Phase 1B Trial More
• Lucid Diagnostics: Laboratory Executes Four New Participating Provider Agreements More
• Mycovia Pharmaceuticals: Presentation of Topline Results From Two Studies Evaluating VIVJOA (oteseconazole) Capsules in Patients With Recurrent Vulvovaginal Candidiasis (RVVC) at the 2022 IDSOG Annual Meeting More
• NKGen Biotech: Appointment of Jill M. Jene, PhD as Chief Business Officer More
• Ocuphire: Extends U.S. Patent Protection for Late-Stage Drug Candidate Nyxol for Reversal of Mydriasis by Five More Years Into 2039 With New Patent Issuance More
• Pasithea Therapeutics: Urges Stockholders to Reject Activist Camac Group's Unjustified Campaign More
• Qx Therapeutics: Development Compound Qxt-101 Has Been Granted Fast-Track Designation by the U.S. FDA for the Treatment of Pulmonary Graft Dysfunction (PGD) Following Lung Transplantation. More
• Rallybio: Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors More
• Umoja Biopharma: Presents New Preclinical Data at the 2022 iPSC Manufacturing Summit on Synthetic Receptor Enabled Differentiation, a Novel Approach for the Differentiation and Expansion of Induced Pluripotent Stem Cells to Generate Cytotoxic Innate Lymphocytes More

• Arcutis Biotherapeutics: Pricing of Public Offering of Common Stock More
• BioXcel Therapeutics: NIH NIDA Grant to Columbia University to Support Further Studies of BXCL501 (Sublingual Dexmedetomidine) for Treating Opioid Withdrawal More
• Elevation Oncology: Expands Pipeline Through Exclusive Licensing of EO-3021 (SYSA1801), a Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate, From CSPC Pharmaceutical Group More
• Elevation Oncology: Secures $50 Million Loan Facility With K2 HealthVentures More
• Legend Biotech: Pricing of Public Offering More
• MAIA Biotechnology: Pricing of Initial Public Offering More
• NC Biotech Center Awards More Than $3.3M in Grants, Loans Across State More
• Novasenta: Completes $40 Million Series A to Advance Novel Cancer Therapeutics More More*
• Ozette: $26MM in Series A Funding for AI-Powered Single-Cell Immune Discovery Technology That Accelerates Therapeutics Across Research and Development More More
• Struck Capital Launches a $15M Fund to Create In-House Startups More
• VerImmune Raises $2.5 Million in Quest to Develop Cancer Therapies More
• Zentalis Pharmaceuticals: Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) More

HOT INVESTOR MANDATES from JULY 28

• Hot Investor Mandate: Healthcare and Technology-Focused VC Invests Broadly Across Healthcare in US, Asia, and Europe, With Strongest Interests in Therapeutics More
• Hot Investor Mandate: Corporate Investment Group Seeks Opportunities That Strategically Align With Parent Company's Interests in Medtech, Open to Companies Across the Globe More
• Hot Investor Mandate: USA-Based Fund Seeks All Therapeutic Areas as Well as Medtech and Digital Health, Allocating Up to $20M in Series A Financings and Beyond More
• Hot Investor Mandate: Investment Firm Supported by Group of High Net Worth Individuals Invests in Medical Devices, Digital Health and Hardware Companies in USA, Europe, and Middle East More

• Fresh off a $10M Cash Infusion, High Point Biotech Firm vTv Therapeutics Has New CEO More More
• MAIA Gets an FDA Approval on Cancer Drug More*
• Michigan Business Incubator to Convert Old Classrooms into Space for Startups More
• Most Recent Tweets From BioStartup News More
• Raleigh Biotech Startup Receives FDA Approval for Testosterone Therapy More
• Student-Centric Startup Incubator Comes to Colorado More

• LSPA: Finance Operations Series – Edition 3 Aug 4
• Biocom California Bay Area Open House & Supplier Showcase Aug 11
• LSPA: Phase to Phase - A Guide to Drug Development Aug 11
• The Bioprocessing Summit 2022 Aug 15-18
• How to be Proactive as a Networker Aug 17
• InnovatorMD World Congress 2022 Aug 17-20
• 2022 Next Generation Dx Summit Aug 22-24
• Real Work: How to Begin the DEI Journey When You Don’t Know Where to Start Aug 23
• LSPA: Tell Me About Your DE&I Series - Edition 4 Sept 1
• Biocom California: Next Gen Autologous Cell Therapy Approaches Sept 8
• Biocom California: Successfully Navigating the USPTO and FDA Sept 8
• LSPA: Legal Answers Workshop Sept 8
• LSPA: The Art of Fundraising - Building Trusted Advisor Relationships Sept 13
• Biocom California: From CFO to Board Room Sept 14
• Biocom California: Health Challenges Only Technology Can Help Solve Sept 21
• Biocom California’s HR Conference for Life Science Sept 22
• FULL EVENT SCHEDULE AT THE BIOCALENDAR

• Director, Biostatistics, Cogent Biosciences - Remote More
• Associate Director, Clinical Operations, Carmot Therapeutics - Berkeley, CA More
• VP, Clinical Operations, Talaris Therapeutics - Louisville, KY More
• Scientist, Discovery, Umoja Biopharma Seattle, WA More
• Director, Medicinal Chemistry, Plexium - San Diego, CA More
• VP Clinical Operations, Eikon Therapeutics - Hayward, CA More